EN
HI
Welcure Drugs & Pharmaceuticals Chart
Welcure Drugs & Pharmaceuticals Share Key Metrics
Volume
1.20 CR
Market Cap
33.37 CR
LTQ@LTP
400@0.27
ATP
0.25
Var Margin
26.98 %
Circuit Range
0.23-0.27
Delivery %
54.97 %
Value
29.98 L
ASM/GSM
No
Market Lot
1
Summary
Welcure Drugs & Pharmaceuticals share price is ₹0.27 as of 13 Jun, 2026. The stock Welcure Drugs & Pharmaceuticals intraday movement has stayed between ₹0.25 and ₹0.27, while on a 52-week basis,Welcure Drugs & Pharmaceuticals price 52 week high is ₹1.44 & its 52 week low is ₹0.23.
In terms of trading activity, Welcure Drugs & Pharmaceuticals has recorded a volume of 11990059 shares, The Welcure Drugs & Pharmaceuticals has a market cap of ₹1235940200 CR. The stock’s Average Traded Price (ATP) stands at ₹0.25, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 400 @ ₹0.27.
Welcure Drugs & Pharmaceuticals operates within a circuit range of ₹0.23 – ₹0.27, with a Value of ₹29.98 L. The Delivery Percentage for the day is 54.97%. Additionally, Welcure Drugs & Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1.
Welcure Drugs & Pharmaceuticals Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
39.75
Sector P/B
2.21
Sec. Div. Yield
77.16
Welcure Drugs & Pharmaceuticals Resistance and Support
Pivot 0.26
Resistance
First Resistance
0.27
Second Resistance
0.28
Third Resistance
0.29
Support
First Support
0.25
Second Support
0.24
Third Support
0.23
Welcure Drugs & Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-29 | Audited Results |
| 2026-02-12 | Quarterly Results |
| 2025-12-05 | Right Issue of Equity Shares |
| 2025-11-27 | To consider raisinf of funds |
| 2025-11-13 | Quarterly Results |
| 2025-09-27 | Others |
| 2025-09-25 | Others |
| 2025-09-02 | A.G.M. |
| 2025-08-28 | Others |
| 2025-08-22 | Bonus issue & Stock Split |
| 2025-08-05 | Quarterly Results & Others |
| 2025-05-29 | Audited Results |
| 2025-05-14 | Others |
| 2025-02-14 | Quarterly Results |
Welcure Drugs & Pharmaceuticals News
Welcure Drugs & Pharmaceuticals Ltd - 524661 - Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Of The Welcure Drugs And Pharmaceuticals Limited Held Today I.E. Friday, 29Th May, 2026
Welcure Drugs & Pharmaceuticals' board approved FY26 results showing a ₹5.49 crore net loss. Auditors issued an unmodified opinion but raised significant concerns about unconfirmed supplier advances of ₹151.26 crores, unverifiable inventory of ₹1,435.24 crores, and non-compliance with MSME disclosure norms, impacting financial transparency.
May 29 2026 20:00:45
Welcure Drugs & Pharmaceuticals Ltd - 524661 - Board Meeting Intimation for Consideration And Approval Of The Audited Financial Results For The Quarter/Year Ended 31St March, 2026 Along With Statement Of Assets And Liabilities And Cash Flow Statement For The Year Ended 31St March, 2026.
Welcure Drugs & Pharmaceuticals' Board of Directors is scheduled to meet on May 29, 2026. The meeting will consider and approve the audited financial results for Q4 FY26 and the full fiscal year.
May 22 2026 16:47:52
Welcure Drugs & Pharmaceuticals Management
| Name | Position |
|---|---|
| Yogeshkumar Prajapati | Non Executive Independent Director |
| Bhumika Pradhan | Non Executive Independent Director |
Welcure Drugs & Pharmaceuticals Similar Stocks
Yarn Syndicate Ltd.
15.46
0.40 (2.66%)
Ecofinity Atomix Ltd.
48.94
-0.51 (1.03%)
Danube Industries Ltd.
4.77
0.01 (0.21%)
Associated Coaters Ltd.
86.00
14.00 (19.44%)
Piotex Industries Ltd.
35.90
0.00 (0.00%)
Scarnose International Ltd.
0.00
0.00 (0.00%)
Jai Mata Glass Ltd.
1.74
0.07 (4.19%)
Chordia Food Products Ltd.
72.52
-1.48 (2.00%)
Welcure Drugs & Pharmaceuticals FAQs
The Buying Price of Welcure Drugs & Pharmaceuticals share is 0.27 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Welcure Drugs & Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Welcure Drugs & Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Welcure Drugs & Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Welcure Drugs & Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.
To assess Welcure Drugs & Pharmaceuticals’s valuation compare Sector P/E, P/B which are 39.75 & 2.21 with sector averages, along with growth rates and financial metrics.
The Market Cap of Welcure Drugs & Pharmaceuticals is 33.37 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Welcure Drugs & Pharmaceuticals share price is 1.44 & 0.23. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Welcure Drugs & Pharmaceuticals belongs to the Miscellaneous sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
